Categories
All-en All-id doc-library-en doc-library-id Hepatitis-en Hepatitis-id HepC-en HepC-id Hiv-en Hiv-id News-en News-id Reports-en Reports-id

WHO Guideline recommendation from a research including Peduli Hati Bangsa

Recently, Yayasan Peduli Hati Bangsa was involved in a research study on self-testing for Hepatitis C.In line with WHO’s goal to eliminate Hepatitis C as a public health threat by 2030, Yayasan Peduli Hati Bangsa together with researchers around the world, conducted a study which was eventually released by WHO as a guide for this…

Categories
All-en Hiv-en News-en

Dolutegravir has FDA Approval for Treating HIV in pediatrics.

Oleh: Food and Drug Administration USA, 12 Juni 2020translated by: Caroline Thomas, 17 Juni 2020 Today, the U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination…